Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study.

Mutagenesis - 12 May 2023

Nichols Lucy, Lawrence Rachel, Haboubi Hasan, Al-Sarireh Bilal, Doak Shareen, Jenkins Gareth

Abstract excerpt

Pancreatic cancer still has one of the worst prognoses of all solid malignancies, despite developments in cancer knowledge and care. Research into pancreatic cancer has not fully translated into clinical improvements and as a result, fewer than 1% of patients survive 10 years post-diagnosis. This bleak outlook for patients could be improved by earlier diagnosis. The human erythrocyte phosphatidylinositol glycan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Damage
Share to Glycosylphosphatidylinositols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphocytes

Share to Micronucleus Tests

Share to Mutation

Share to Pancreatic Neoplasms

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 37006185
DOI: 10.1093/mutage/gead006
PMCID: PMC10181792

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study.PMID 37006185Read ↗

The PIG-A gene mutation assay in human biomonitoring and diseaseSemantic proximity Read ↗

The PIG-A gene mutation assay in human biomonitoring and disease.Semantic proximity Read ↗

The utility of a novel blood based biomarker in the diagnosis of pancreatic cancerSemantic proximity Read ↗

Erythrocyte-Based Pig-a Gene Mutation Assay.Semantic proximity Read ↗

Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?Semantic proximity Read ↗

Erythrocyte-based Pig-a gene mutation assay.Semantic proximity Read ↗

The in vitro PIG-A gene mutation assay: glycosylphosphatidylinositol (GPI)-related genotype-to-phenotype relationship in TK6 cells.Semantic proximity Read ↗

Monitoring humans for somatic mutation in the endogenous PIG-a gene using red blood cells.Semantic proximity Read ↗

[The PIG-A gene as a new biomarker of mutagenesis: proof of concept and technical specifications].Semantic proximity Read ↗

A quantitative measurement of the human somatic mutation rate.Semantic proximity Read ↗

The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells.Semantic proximity Read ↗

Glycophosphatidylinositol-anchored protein deficiency as a marker of mutator phenotypes in cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.